TAKEDA PHARMACEUTICAL CO. LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of TKD for the last quarter is 7.13 B EUR, and it's 8.05% higher compared to the previous quarter. The net income of Q3 23 is 678.82 M EUR.